Calcium-permeable AMPA receptors in the VTA and nucleus accumbens after cocaine exposure: when, how, and why?
- Published in:
- Frontiers in Molecular Neuroscience, 2012, v. 5, p. 1, doi. 10.3389/fnmol.2012.00072
- By:
- Publication type:
- Article
Works matching DE "AMPA receptor antagonists"
Results: 19
1
2
Perampanel, a potent AMPA receptor antagonist, protects against tetramethylenedisulfotetramine-induced seizures and lethality in mice: comparison with diazepam.
- Published in:
- Archives of Toxicology, 2021, v. 95, n. 7, p. 2459, doi. 10.1007/s00204-021-03053-9
- By:
- Publication type:
- Article
3
Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test
- Published in:
- Psychopharmacology, 2014, v. 231, n. 11, p. 2291, doi. 10.1007/s00213-013-3378-0
- By:
- Publication type:
- Article
4
Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures.
- Published in:
- Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 1215, doi. 10.2147/NDT.S83842
- By:
- Publication type:
- Article
5
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist inhibits apoptosis of retinal ganglion cells in a rabbit model of optic nerve injury.
- Published in:
- Neural Regeneration Research, 2012, v. 7, n. 10, p. 731, doi. 10.3969/j.issn.1673-5374.2012.10.002
- By:
- Publication type:
- Article
6
Adjunctive perampanel for partial‐onset seizures.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
7
Adjunctive perampanel in partial‐onset seizures: Asia‐Pacific, randomized phase III study.
- Published in:
- Acta Neurologica Scandinavica, 2018, v. 137, n. 4, p. 392, doi. 10.1111/ane.12883
- By:
- Publication type:
- Article
8
Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings.
- Published in:
- Acta Neurologica Scandinavica, 2018, v. 137, n. 4, p. 378, doi. 10.1111/ane.12879
- By:
- Publication type:
- Article
9
Perampanel Study 207: long-term open-label evaluation in patients with epilepsy.
- Published in:
- Acta Neurologica Scandinavica, 2012, v. 126, n. 4, p. 263, doi. 10.1111/ane.12001
- By:
- Publication type:
- Article
10
Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3-a)Quinoxalin-4(5H)-one Derivatives as AMPA Receptor Antagonists.
- Published in:
- Journal of Heterocyclic Chemistry, 2013, v. 50, n. 5, p. 1202, doi. 10.1002/jhet.714
- By:
- Publication type:
- Article
11
The AMPA receptor antagonist perampanel is a new hope in the treatment for epilepsy.
- Published in:
- Fundamental & Clinical Pharmacology, 2014, v. 28, n. 5, p. 473, doi. 10.1111/fcp.12081
- By:
- Publication type:
- Article
12
The Impact and Mechanism of a Novel Allosteric AMPA Receptor Modulator LCX001 on Protection Against Respiratory Depression in Rodents.
- Published in:
- Frontiers in Pharmacology, 2019, p. N.PAG, doi. 10.3389/fphar.2019.00105
- By:
- Publication type:
- Article
13
Perampanel: Does it have broad‐spectrum potential?
- Published in:
- Epilepsia (Series 4), 2019, v. 60, p. 22, doi. 10.1111/epi.14456
- By:
- Publication type:
- Article
14
The role of AMPA receptors and their antagonists in status epilepticus.
- Published in:
- Epilepsia (Series 4), 2018, v. 59, n. 6, p. 1098, doi. 10.1111/epi.14082
- By:
- Publication type:
- Article
15
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior.
- Published in:
- Epilepsia (Series 4), 2017, v. 58, n. 2, p. 231, doi. 10.1111/epi.13629
- By:
- Publication type:
- Article
16
Introduction: Perampanel-New mode of action and new option for patients with epilepsy.
- Published in:
- Epilepsia (Series 4), 2014, v. 55, p. 1, doi. 10.1111/epi.12495
- By:
- Publication type:
- Article
17
AMPA Receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 11, p. 1922, doi. 10.1111/epi.12378
- By:
- Publication type:
- Article
18
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 8, p. 1481, doi. 10.1111/epi.12212
- By:
- Publication type:
- Article
19
Perampanel: A Selective AMPA Antagonist for Treating Seizures.
- Published in:
- Epilepsy Currents, 2013, v. 13, n. 6, p. 269, doi. 10.5698/1535-7597-13.6.269
- Publication type:
- Article